首页 | 本学科首页   官方微博 | 高级检索  
检索        

双黄连口服液联合利巴韦林雾化吸入治疗小儿疱疹性咽峡炎临床探讨
引用本文:徐锦.双黄连口服液联合利巴韦林雾化吸入治疗小儿疱疹性咽峡炎临床探讨[J].中医临床研究,2014(5):34-35.
作者姓名:徐锦
作者单位:漯河市郾城区人民医院;
摘    要:目的:探讨双黄连口服液联合利巴韦林雾化吸入治疗小儿疱疹性咽峡炎临床疗效。方法:对照组予以利巴韦林雾化吸入,观察组在对照组基础上口服双黄连口服液,观察两组临床疗效、临床症状、体征消失时间。结果:观察组总有效率91.53%明显优于对照组80.0%(P<0.05)。观察组患儿退热时间、疱疹消失时间、淋巴结肿大消失时间、咽痛消失时间明显短于对照组(P<0.05)。结论:双黄连口服液联合利巴韦林雾化吸入治疗小儿疱疹性咽峡炎临床疗效明显,无不良反应,值得推广。

关 键 词:利巴韦林  双黄连口服液  小儿  疱疹性咽峡炎  疗效

Discussion on treating herpes angina in children by the SHL oral liquid plus ribavirin inhalation therapy
Abstract:Objective: To investigate the clinical efficacy of SHL oral liquid plus ribavirin inhalation therapy on herpes angina in children. Methods:The control group received ribavirin inhalation, observation group was given SHL oral liquid based on the control group. The clinical efficacy, clinical symptoms and signs disappeared time were observed. Results:The total efficiency 91.53%of the observation group was better than the control group 80.0%(P〈0.05). Fever time, herpes disappearance time, lymphadenopathy disappearance time, sore throat disappearance time of observation group significantly were shorter than the control group (P〈0.05). Conclusion:SHL oral liquid plus ribavirin inhalation treatment of has significant clinical curative effect on herpes angina, with no adverse reaction, worthy of promotion.
Keywords:Ribavirin  SHL oral liquid  Children  Herpes angina  Efficacy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号